Evaluation of the Effectiveness of Virtual Reality Self-rehabilitation in the Treatment of Facial Paralysis and Synkinesis
RéMiFaSy
1 other identifier
interventional
100
1 country
1
Brief Summary
Peripheral facial palsy affects 15 to 40 people per 100,000 inhabitants and induces important functional and social repercussions. Synkinesis is a frequent after-effect of facial palsy recovery, consisting of involuntary facial spasms that disturb the gestural harmony and can go as far as a painful hypertonic spasm. More than 55% of patients recovering from facial palsy will develop transient or permanent synkinesis. These facial hypertonias have two main causes: imperfect axonal regeneration, which is all the more important as the damage is proximal, and hyperexcitability of the facial nerve nucleus due to a lack of central control. Management is therefore essential for the functional restoration of the face, especially since synkinesis do not evolve spontaneously. The main treatments are currently botulinum toxin injection, acting on the motor plate, and functional rehabilitation, consisting on local muscle relaxation and central motor control work. In recent years, therapies based on biofeedback and acting on central motor control have shown interesting results, and technological advances in virtual reality have made it possible to deepen this treatment in patients suffering from stroke, limb trauma or Parkinson's disease. In this project, the investigators evaluate the contribution of virtual reality to the management of facial palsy, and hypothesize that self-rehabilitation using this technology will improve motor control of the skin muscles and reduce complications related to their hypertonia such as synkinesis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 6, 2022
CompletedStudy Start
First participant enrolled
September 6, 2022
CompletedFirst Posted
Study publicly available on registry
September 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2025
CompletedSeptember 21, 2022
September 1, 2022
2 years
September 6, 2022
September 15, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
variation of number of involuntary facial spasm between both groups of patients
variation of synkinesis in patients with recent onset (≤ 12 months) peripheral facial palsy compared with the conventional rehabilitation protocol
12 months
Study Arms (2)
Experimental arm
EXPERIMENTALpatients benefiting from rehabilitation associated with virtual reality
Control arm
ACTIVE COMPARATORpatients benefiting from rehabilitation without virtual reality
Interventions
Patient watches an avatar of his face performing different movements on a screen, and will have to imagine performing these movements without actually doing them.
Eligibility Criteria
You may qualify if:
- Patient with recent onset peripheral facial palsy (≤ 12 months).
- Patient with peripheral facial palsy of grade ≥ III on the House \& Brackmann score
- Patient of legal age (≥ 18 years)
- Patient with appropriate information and informed consent
You may not qualify if:
- Patient with central facial palsy
- Patient with peripheral facial palsy of \> 12 months onset
- Patient with peripheral facial palsy of grade \< III House \& Brackmann score
- Patient who has previously undergone palliative surgery
- Patient undergoing a botulinum toxin injection protocol
- Patients benefiting from enhanced protection, i.e. minors, persons deprived of their liberty by a judicial or administrative decision, persons staying in a health or social institution, adults under legal protection, pregnant or breast-feeding women and patients in emergency situations
- Patients who have not provided informed consent
- Patients with cognitive disorders that do not allow them to follow the proposed self-education protocol
- Blind or visually impaired patients (visual acuity of the better eye after correction ≤ 4/10)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens Picardie
Amiens, Picardie, 80054, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 6, 2022
First Posted
September 21, 2022
Study Start
September 6, 2022
Primary Completion
September 1, 2024
Study Completion
September 1, 2025
Last Updated
September 21, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share